SynthesisObesity surgery2025
Prevalence of Liver Dysfunction After One-Anastomosis Gastric Bypass: A Systematic Review and Single-Arm Meta-analysis.
Synthesis in Obesity surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Laparoscopic Reversal of One-Anastomosis Gastric Bypass After Sleeve Gastrectomy: A Case Report.The American journal of case reports · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundOne-anastomosis gastric bypass (OAGB) has gained popularity as a bariatric operation due to its shorter operation time and lower perioperative complication rates, compared with Roux-en-Y gastric bypass (RYGB). However, OAGB is associated with short and long-term complications. Notably, in some reports a subset of patients developed liver dysfunction after OAGB, in some cases causing death or requiring liver transplantation.
methodsA systematic review and meta-analysis were conducted following PRISMA guidelines. MEDLINE, EMBASE and PubMed databases were searched for studies published from 1946 to June 2024, focusing on the prevalence of liver dysfunction post-OAGB. Data extraction and quality assessment were performed by two independent reviewers. Statistical analysis includes pooled prevalence estimates, subgroup analysis against biliopancreatic limb length and regions of the included studies, sensitivity analysis and public bias assessment by Egger's test.
resultsOf the 3223 identified articles, 7 studies met the inclusion criteria, involving 2944 patients, with 91 patients developing liver dysfunction post-OAGB. The pooled prevalence of liver dysfunction was 1.2% (95% CI 0.3-2.1%), with significant heterogeneity (I
conclusionThe prevalence of liver dysfunction post OAGB is low but clinically significant, warranting intense postoperative care and regular liver function monitoring. The lack of extensive data on this topic is a limitation, but as the first study to summarise current evidence, this study provides a foundation for future research.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.